CapForce Inc. (CFOR)
Stock analysis · OTC · Financial Services · Financial - Capital Markets
CapForce Inc. (CFOR) is a publicly traded company in the Financial Services sector. Latest price: $9.00. Market cap $94.64M. Trailing PE 1.68. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →1-Year Price
Earnings
Proprietary Signals
About CapForce Inc.
CapForce Inc. is a precision medicine company dedicated to developing and commercializing sophisticated molecular microbiology solutions. Its mission is to address life-threatening infectious diseases for patients in the United States and across international markets. The company's diverse product range includes Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel diagnostic tests, and SARS CoV-2 testing kits. Beyond its product line, CapForce extends its offerings to include laboratory services, collaboration services (such as funded software arrangements), and licensing agreements. Additionally, the company provides listing sponsorship and consultancy services. Formerly known as OpGen, Inc., the entity officially changed its name to CapForce Inc. in February 2026. CapForce Inc. was established in 2001 and maintains its headquarters in Clarksburg, Maryland.
Valuation
| P/E (TTM) | 1.68× |
|---|---|
| P/S (TTM) | 1.24× |
| P/B | 1.50× |
| PEG | 0.02× |
| P/FCF (TTM) | -62.25× |
| EV / EBITDA | 1.48× |
| EV / Sales | 1.27× |
| Earnings Yield | 55.90% |
| Free Cash Flow Yield | -1.61% |
Fundamentals
| Enterprise Value | $96.45M |
|---|---|
| Revenue (TTM) | $76.20M |
| Net Income (TTM) | $52.90M |
| Free Cash Flow (TTM) | -$1.56M |
| Net Debt | $1.82M |
| Working Capital | $38.84M |
| Gross Margin | 89.53% |
| Operating Margin | 84.82% |
| Net Margin | 81.73% |
| Return on Equity | 168.84% |
| Return on Invested Capital | 83.36% |
Peers
Recent News
- No recent news available.
Related
Browse more tickers: sitemap